Diagnosis and management of primary hyperparathyroidism in Europe

por Langdahl, B.L., Ralston, S.H.
Publicado 2012

A genome-wide genomic score added to standard recommended stratification tools does not improve the identification of patients with very low bone mineral density

por Therkildsen, J., Rohde, P.D., Nissen, L., Thygesen, J., Hauge, E.-M., Langdahl, B.L., Boettcher, M., Nyegaard, M., Winther, S.
Publicado 2023

Temporomandibular disorders and psychosocial status in osteogenesis imperfecta - a cross-sectional study

por Bendixen, K. H., Gjørup, H., Baad-Hansen, L., Dahl Hald, J., Harsløf, T., Schmidt, M. H., Langdahl, B. L., Haubek, D.
Publicado 2018

Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS)

por Fahrleitner-Pammer, A., Langdahl, B. L., Marin, F., Jakob, F., Karras, D., Barrett, A., Ljunggren, Ö., Walsh, J. B., Rajzbaum, G., Barker, C., Lems, W. F.
Publicado 2010

A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab

por McClung, M. R., Bolognese, M. A., Brown, J. P., Reginster, J.-Y., Langdahl, B. L., Maddox, J., Shi, Y., Rojeski, M., Meisner, P. D., Grauer, A.
Publicado 2020